Protalix BioTherapeutics, Inc. Share Price
AMEX: PLX | Micro CapProtalix BioTherapeutics, Inc. Stock Performance
Protalix BioTherapeutics, Inc. Share Price Today
As of 30 October 2026, Protalix BioTherapeutics, Inc.'s share price is $2.61. The stock opened at $2.64, compared to its previous close of $2.59. During today's trading session, Protalix BioTherapeutics, Inc.'s share price traded between $2.60 and $2.67, with an average price of $2.63. Over the past 52 weeks, the stock has recorded a high of $3.19 and a low of $1.65. In terms of performance, Protalix BioTherapeutics, Inc.'s share price has risen by 21.96% over the last six months and is up 9.89% on a year-on-year basis.
Protalix BioTherapeutics, Inc. Share Price Chart
Protalix BioTherapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Protalix BioTherapeutics, Inc. Annual Profit & Loss
All figures in USD
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Protalix BioTherapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.73 | $2.60 | -5.27% |
Sep 2026 | $2.62 | $2.75 | +5.36% |
Aug 2026 | $2.45 | $2.61 | +9.66% |
Jul 2026 | $2.33 | $2.38 | +2.81% |
Jun 2026 | $2.10 | $2.31 | +9.98% |
May 2026 | $2.14 | $2.10 | -1.64% |
Apr 2026 | $2.21 | $2.14 | -2.28% |
Mar 2026 | $2.80 | $2.19 | -23.96% |
Feb 2026 | $2.35 | $2.88 | +24.14% |
Jan 2026 | $1.83 | $2.32 | +29.25% |
Dec 2025 | $1.77 | $1.79 | +0.28% |
Nov 2025 | $2.38 | $1.79 | -24.63% |